Label (71610 0839 30)
Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71610-839
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71610-839). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Zolpidem Tartrate (8bb9d44d 6ee5 4174 8d42 52078de66779 01)
Im-2 (8bb9d44d 6ee5 4174 8d42 52078de66779 02)
This data table shows the zolpidem plasma concentrations in ng/mL for 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate release over a period of 8 hours. The concentrations are measured at various timepoints ranging from 0.0 hours to 8.0 hours.*
Aphena (Aphena)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
